A complete loss of BRM (SMARCA2) expression and a retention of INI1 (SMARCB1) in the tumor cells was suggestive of unusual malignant rhabdoid tumor. After the initial diagnosis, treatment was immediately started with vincristine, cyclophosphamide, and doxorubicin for a five-day course. Here, SMARCA2 is linked to neoplasm.